Target intelligence / Profile preview

Family with sequence similarity 217, member B (FAM217B)

Target
FAM217B
Molecular classification
Other (Uncharacterized protein family; not classified as receptor, enzyme, transporter, transcription factor, etc.[3][5].)
01

Overview

Family with sequence similarity 217, member B (FAM217B) is a human protein of unknown function, located primarily in the cytosol and nucleoplasm[1][5]. Studies show that its promoter may undergo hypermethylation and transcriptional silencing in disorders such as ulcerative colitis, where such silencing could contribute to disease pathogenesis, possibly through the disruption of gene expression in intestinal epithelium[1]. While its consistent epigenetic alteration marks it as a gene of interest and a potential biomarker, the biological role of FAM217B—in cellular signaling, immune modulation, or epithelial maintenance—remains to be fully established. There is currently no evidence that FAM217B directly functions as a receptor, enzyme, or other canonical drug target, nor are there known drugs designed to act on this gene product[1][3][5]. FAM217B is primarily notable as an epigenetically regulated gene, with potential biomarker implications; not a characterized receptor, enzyme, or regulated drug target at this time[1][5]. Its most common aliases are C20orf177 and dJ551D2.5, and its function is "uncharacterized protein" or "other" in terms of molecular classification[3][5]. It is recorded as a protein-coding gene with some disease associations by bioinformatic correlation, not by mechanism-driven validation[5].

Other names
C20orf177dJ551D2.59030418K01RikRGD1311952
02

Biological functions

Other (Precise biological function not fully elucidated[1][3][5].)
03

Disease associations

Epigenetic silencing of FAM217B has been observed in ulcerative colitis, suggesting possible involvement in inflammatory bowel disease[1]. It has been highlighted as a gene of interest/pathogenesis-related, rather than a causal or validated driver gene. Also nominated as a potential biomarker in cancer context[1].
04

Biomarkers

DNA methylation status of FAM217B promoter region (potential, especially in ulcerative colitis and possibly some cancers[1])

Beyond the preview

Go deeper on Family with sequence similarity 217, member B (FAM217B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 217, member B (FAM217B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call